Unknown

Dataset Information

A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.


ABSTRACT: Light chain (AL) amyloidosis is a rare disease associated with significant, irreversible organ dysfunction and high case fatality. An observational study was conducted to assess health-related quality of life (HRQoL) in patients treated for AL amyloidosis between 1994 and 2014 with both high dose melphalan and stem cell transplantation (HDM/SCT) or non-SCT chemotherapy regimens. The SF-36v1® Health Survey (SF-36) was administered to assess HRQoL during clinic visits. Analysis of variance was used to compare pre- and post-treatment HRQoL within each treatment group to an age- and gender-adjusted general population (GP) normative sample. Cox proportional hazard models were fit to examine associations between pre-treatment levels of HRQoL and mortality within 1 and 5 years after in

SUBMITTER: Sanchorawala V 

PROVIDER: S-EPMC5697591 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature